SCHEMBL29424867

SCHEMBL29424867

COc1ncnc2c1ncn2Cc1ccc(B(O)O)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 1/20 0.56
▸ DAPK1 P53355 1/20 0.53
▸ FLT4 P35916 1/20 0.51
▸ KDR P35968 1/20 0.51
▸ FGFR1 P11362 4/20 0.46
▸ FGFR4 P22455 4/20 0.46
▸ ADORA2A P29274 1/20 0.44
▸ PI4KA P42356 1/20 0.44
▸ PI4K2B Q8TCG2 1/20 0.44
▸ PI4K2A Q9BTU6 1/20 0.44
▸ PI4KB Q9UBF8 1/20 0.44
▸ HDAC6 Q9UBN7 2/20 0.44
▸ HDAC1 Q13547 1/20 0.44
▸ SLC29A1 Q99808 1/20 0.42
▸ PDE4A P27815 1/20 0.42
▸ PDE4B Q07343 1/20 0.42
▸ PDE4C Q08493 1/20 0.42
▸ PDE4D Q08499 1/20 0.42
▸ TAAR1 Q96RJ0 1/20 0.42
▸ FGFR2 P21802 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22533420 1.00 HPGD (0.56) HPGDDAPK1FLT4KDRFGFR1
9-Benzyl-6-Methoxy-9H-Purine SCHEMBL28939425 0.83 HPGD (0.77) HPGDDAPK1FLT4KDRADORA2A
SCHEMBL29424838 0.82 HDAC6 (0.62) FGFR1FGFR4ADORA2API4KAPI4K2B
SCHEMBL22533476 0.82 HDAC6 (0.62) FGFR1FGFR4ADORA2API4KAPI4K2B
SCHEMBL22084386 0.81 ADORA2A (0.47) DAPK1FGFR1FGFR4ADORA2API4KA
SCHEMBL22533785 0.81 ADORA2A (0.68) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL29424732 0.81 ADORA2A (0.68) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL22533572 0.80 SCN9A (0.45) —
SCHEMBL22533657 0.80 HPGD (0.37) HPGDDAPK1FLT4KDRADORA2A
SCHEMBL28717002 0.80 L3MBTL1 (0.41) HPGDMEN1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114040915-A Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors 里伯赛恩斯有限责任公司 2022-02-11 — — CN disclosed
Send feedback